Skip to main contentSkip to navigationSkip to search

UK Modern Slavery Act Transparency Statement

The UK Modern Slavery Act requires companies to disclose any efforts that are taken to address slavery, forced and compulsory labour and human trafficking in their production and supply chain. In below statement the efforts taken by Camurus on how to tackle the challenge of modern slavery and human trafficking throughout our supply chain, in line with the UK Modern Slavery Act, are stated.

This statement is made pursuant to Section 54 of the Modern Slavery Act 2015. It constitutes Camurus Slavery and human trafficking statement for the financial year 2021, and with updated information for the period January to September 2022.

Camurus, is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. Camurus' products are based on the company's proprietary FluidCrystal® technology and are designed to address important unmet medical needs, with the potential to make a significant difference in the daily life of patients. Camurus’ clinical pipeline includes product candidates for the treatment of opioid dependence and pain, endocrine diseases and cancer and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies. Camurus aims to provide sustainable solutions that reduce environmental impact and create real value for all stakeholders. Camurus has over 170 employees with headquarters in Lund (Sweden), and larger regional offices in Cambridge (UK), Mannheim (Germany) and Sydney (Australia). Total revenue in 2021 amounted to SEK 601 million, and 688 million SEK for the period January to September 2002. Learn more on

Camurus’ supply chain includes suppliers of goods, work, and services, which are required for the company’s own operations and external manufacturer of Camurus’ products. The company does not produce any products itself, thus the production as well as input material to these products are sourced from suppliers. Suppliers are in general contracted centrally, but each regional office also has local suppliers for minor supplies of local goods and services.

Camurus’ business and success rely on the trust and confidence from the stakeholders. Modern slavery in all its forms including servitude, forced labour and compulsive labour and human trafficking is completely unacceptable, a crime act and violation of fundamental human rights. Camurus recognizes that modern slavery is a global issue that may affect the organization, the company’s supply chains alike.  

Camurus operates according to the company’s Code of Conduct, which is based on core values of reliability, responsibility, and focused innovation. Camurus also requests suppliers and business partners to conduct their business in a lawful and ethical manner. This includes preventing or eliminating modern slavery in all its forms. For more information on Camurus’ Code of Conduct, please visit Training on the company Code of Conduct is mandatory for all employees.

Camurus’ suppliers directly related to the production and transportation of the company’s products are assessed through a supplier sustainability risk evaluation. The risk of human rights breaches and modern slavery are parameters in this evaluation, which was initiated by Camurus during 2022.

Camurus has not identified any occurrences of modern slavery or human trafficking in neither the company’s own businesses, nor in the supply chain during 2021, nor during the period January to September 2022. Camurus is in the process of implementing a Supplier Code of Conduct, which includes requirements related to amongst others, forced labour and child labour, and which shall be acknowledged by the suppliers, as part of the contractual arrangement with Camurus. Camurus is also in the process of expanding our whistleblowing mechanisms, to allow also third parties (including suppliers, consultants etc.) to report suspected misconduct involving Camurus businesses.

This statement has been approved by the Camurus on November 30, 2022.

Jonas Duborn, Head of Compliance & Compliance Officer                            
Torsten Malmström, Chief Technical Officer

UK-NPR-2200126 Dec 2022